Conformational Rank Conditioned Committees for Machine Learning-Assisted Directed Evolution
Mia Adler, Carrie Liang, Brian Peng, Oleg Presnyakov, Justin M. Baker, Jannelle Lauffer, Himani Sharma, Barry Merriman

TL;DR
This paper introduces a rank-conditioned committee framework for machine learning-assisted directed evolution, enabling better separation of uncertainties and improving antibody discovery by leveraging conformational rankings.
Contribution
The paper proposes a novel rank-conditioned committee approach that explicitly models conformational uncertainty in MLDE, enhancing its effectiveness in antibody evolution tasks.
Findings
Significant improvements in SARS-CoV-2 antibody docking performance
Effective separation of conformational and epistemic uncertainties
Scalable approach for therapeutic antibody discovery
Abstract
Machine Learning-assisted directed evolution (MLDE) is a powerful tool for efficiently navigating antibody fitness landscapes. Many structure-aware MLDE pipelines rely on a single conformation or a single committee across all conformations, limiting their ability to separate conformational uncertainty from epistemic uncertainty. Here, we introduce a rank -conditioned committee (RCC) framework that leverages ranked conformations to assign a deep neural network committee per rank. This design enables a principled separation between epistemic uncertainty and conformational uncertainty. We validate our RCC-MLDE approach on SARS-CoV-2 antibody docking, demonstrating significant improvements over baseline strategies. Our results offer a scalable route for therapeutic antibody discovery while directly addressing the challenge of modeling conformational uncertainty.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsvaccines and immunoinformatics approaches · Monoclonal and Polyclonal Antibodies Research · CRISPR and Genetic Engineering
